Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CSBR
#4090
Champions Oncology, Inc.
5.8
7
USD
+2.26%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.26%
Aylık Değişim
-5.63%
6 aylık değişim
-10.52%
Yıllık Değişim
-25.70%
Önceki Kapanış
5.7
4
Open
5.8
4
Bid
Ask
Low
5.8
4
High
5.8
7
Hacim
2
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CSBR
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
13.42 M
13.52 M
13.46 M
13.59 M
13.78 M
—
Valuation ratios
Enterprise value
139.26 M
94.17 M
55.3 M
63.31 M
88.72 M
344.11 M
Price to earnings ratio
536.5
190.75
-12.46
-8.98
21.67
42.22
Price to sales ratio
3.81
2.2
1.22
1.31
1.79
6.76
Price to cash flow ratio
-93.02
16.63
16.57
-10.71
13.81
64.24
Price to book ratio
21.05
11.88
14.2
-34.53
27.04
45.86
Enterprise value to EBITDA ratio
-4.37
-2.52
-1.1
-1.19
-2.27
-7.84
Profitability ratios
Return on assets %
0.01
0.02
-0.16
-0.28
0.15
-0.07
Return on equity %
0.05
0.06
-1.15
3.82
1.25
-0.61
Return on invested capital %
6.79
9.14
-74.86
-106.42
69.71
-41.22
Gross margin %
47.74
51.88
45.18
41.38
50.15
182.36
Operating margin %
0.89
1.24
-9.76
-14.67
8
-20.45
EBITDA margin %
-77.69
-75.97
-93.05
-106.13
-68.66
-362.96
Net margin %
0.88
1.12
-9.9
-14.51
8.26
-17.87
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.13
1.13
0.9
0.63
0.94
3.8
Inventory turnover
—
—
—
—
—
—
Asset turnover
1.7
1.56
1.55
1.66
1.95
1.9
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.12
0.46
0.29
-0.45
0.52
0.31
EBIT per share
-2.27
-2.74
-3.86
-4.12
-2.86
-3.85
EBITDA per share
-2.19
-2.63
-3.7
-3.93
-2.74
-3.7
Total debt per share
—
—
—
—
—
—
Cash per share
0.32
0.64
0.75
0.19
0.69
2.54
Net current asset value per share
0.87
1.39
1.44
1.01
1.57
6.02
Tangible book value per share
0.49
0.62
0.32
-0.17
0.24
1.02
Working capital per share
0.1
0.15
-0.17
-0.58
-0.1
-0.32
Book value per share
0.51
0.64
0.34
-0.14
0.26
1.12
Haberler
Champions Oncology AACR toplantısında sekiz çalışma sunacak
Champions Oncology yönetim kuruluna Brian Alexander’ı atadı
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Champions Oncology kazancı $0,04 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
Champions Oncology earnings missed by $0.04, revenue topped estimates
Champions Oncology reports Q3 revenue of $16.6 million
Champions Oncology kazancı $0,05 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Champions Oncology earnings beat by $0.05, revenue topped estimates
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Champions Oncology 2025 2. Çeyrek kazanç çağrısı: Güçlü gelir artışı görüldü
Earnings call transcript: Champions Oncology Q2 2025 sees strong revenue growth
Top Stocks With Earnings This Week: Micron, FuelCell, Carnival - Micron Technology (NASDAQ:MU)